TY  - CHAP
AU  - Vahidfar, Nasim
AU  - Bakhshi Kashi, Mohsen
AU  - Afshar, Saeed
AU  - Sheikhzadeh, Peyman
AU  - Farzanefar, Saeed
AU  - Salehi, Yalda
AU  - Delpasand, Ebrahim
AU  - Molloy, Eóin N.
AU  - Mirzaei, Siroos
AU  - Ahmadzadehfar, Hojjat
AU  - Eppard, Elisabeth
A3  - Adelaja Osibote, Otolorin
A3  - Eppard, Elisabeth
TI  - Recent Advances of Copper-64 Based Radiopharmaceuticals in Nuclear Medicine
PB  - IntechOpen
M1  - DZNE-2025-00183
SP  - 1 - 24
PY  - 2024
AB  - Copper radioisotopes including copper-60/61/62, and -64 exhibit a wide range of decay characteristics, making them appropriate choices for diagnostic/therapeutic (theranostic) applications in nuclear medicine. One notable feature of copper is the feasible coordination chemistry, which makes radiolabeling of a wide range of chemical structures including antibodies, proteins, peptides, and other biologically relevant small molecules possible. This chapter will summarize common radiopharmaceuticals of copper-64 and their radiation dosimetry in order to highlight recent improvements of positron emission tomography diagnostics.
LB  - PUB:(DE-HGF)7
DO  - DOI:10.5772/intechopen.1003993
UR  - https://pub.dzne.de/record/276102
ER  -